Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Molecular Cancer Research : MCR|October 25, 2023
Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mitochondrial Protein Import and FunctionMary Oluwadamilola Haastrup, Kunwar Somesh Vikramdeo, Shashi Anand, et al.
Seminars in Cancer Biology|August 21, 2021
Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease managementMohammad Aslam Khan, Kunwar Somesh Vikramdeo, Sarabjeet Kour Sudan, et al.
Iscience|December 13, 2023
MYB exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancerMohammad Aslam Khan, Srijan Acharya, Shashi Anand, et al.
Cancer Health Disparities|August 24, 2019
Looking at cancer health disparities without the colored lensesMohammad Aslam Khan, Girijesh Kumar Patel, Sanjeev Kumar Srivastava, et al.
British Journal of Cancer|February 3, 2017
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCKGirijesh Kumar Patel, Mohammad Aslam Khan, Arun Bhardwaj, et al.
Carcinogenesis|September 10, 2016
Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talkCourey Averett, Arun Bhardwaj, Sumit Arora, et al.
Scientific Reports|August 12, 2018
Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophagesSachin Kumar Deshmukh, Nikhil Tyagi, Mohammad Aslam Khan, et al.
NPJ Breast Cancer|July 24, 2025
Subtype- and race-specific variations in the immune landscape of breast cancer: therapeutic implicationsAmod Sharma, Sarabjeet Kour Sudan, Kunwar Somesh Vikramdeo, et al.
EMBO Reports|January 2, 2023
MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogrammingShashi Anand, Mohammad Aslam Khan, Haseeb Zubair, et al.
The Journal of Biological Chemistry|May 3, 2020
Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancerMohammad Aslam Khan, Sanjeev Kumar Srivastava, Haseeb Zubair, et al.
Pageof 5